SABIC (2010) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Dec, 2025Executive summary
Q1 2025 revenue was stable at $9.23 billion (SAR 34.59 billion), flat sequentially and up 6% year-over-year, despite market challenges.
Net loss was $323 million (SAR 1.21 billion), an improvement from the previous quarter but down year-over-year.
EBITDA was $670 million (SAR 2.5 billion), impacted by $300 million in restructuring costs; adjusted EBITDA was $1 billion (SAR 3.7 billion), up 7% sequentially.
Strategic workforce optimization and restructuring initiatives are expected to yield over $90 million in annual cost savings.
Major growth projects in China and Saudi Arabia are progressing on schedule, with sustainability milestones achieved.
Financial highlights
Revenue for Q1 2025 was $9.23 billion (SAR 34.59 billion), flat quarter-over-quarter and up 6% year-over-year.
EBITDA margin before special items reached 11% in Q1 2025, up from 10% in Q4 2024.
Net income was negative $323 million (SAR 1.21 billion), improved from the previous quarter.
Free cash flow was negative at $0.36 billion (SAR 1.35 billion) due to lower cash from operations and restructuring costs.
S&P upgraded the long-term credit rating to A-plus.
Outlook and guidance
2025 capital investment is projected between $3.5 billion and $4 billion.
Guidance is based on slow economic growth, with global GDP growth expected at 2.2–2.97%.
Focus remains on operational excellence, transformation, and selective growth.
Latest events from SABIC
- Q3 2024 revenue up 3% to $9.83B, stable EBITDA, and key divestments amid market headwinds.2010
Q3 202413 Mar 2026 - Adjusted profits remained resilient and free cash flow rose 17% despite margin pressure.2010
Q4 20255 Mar 2026 - Q2 2024 delivered strong profit growth, portfolio optimization, and top-tier sustainability progress.2010
Q2 20242 Feb 2026 - EBITDA rose 2% to $5.2B as net income rebounded and dividends reached $2.72B.2010
Q4 20247 Jan 2026 - Adjusted EBITDA jumped 40% in Q2 2025, but net loss was $1.1B from major impairments.2010
Q2 202523 Nov 2025 - Revenue dipped but EBITDA and free cash flow were resilient as transformation gains continued.2010
Q3 20253 Nov 2025